CureBay is a rural healthcare startup. CureBay has raised approximately ₹100 crore in a pre-Series C funding round. The funding round was led by IvyCap Ventures. The capital injection includes ₹69 crore in equity through IvyCap Ventures and other existing investors, with more than ₹30 crore from financial institutions such as Trifecta Capital, Alteria Capital, and VentureSoul Partners. This significant investment will allow the company to expand its operations in unserved areas of India, scale up its business, and enhance its foundational healthcare delivery system.

Capital deployment and comprehensive service offerings

The fresh financial infusion will be channeled into enhancing CureBay’s physical and digital footprint in the country, including an imminent operational presence in Andhra Pradesh. The company also intends to invest heavily in expanding its geographical reach, as well as its technology and artificial intelligence capabilities. 

With these technological developments, the company aims to optimize its health screening infrastructure, deepen patient knowledge, and aid clinical decisions in its rural network to provide optimal care and efficiency.

CureBay was founded in 2021 by Priyadarshi Mohapatra, Shobhan Mahapatra, and Sanjay Swain. Its startup has multiple clinics throughout its vast network, each equipped with technology, arranged specifically to treat patients in underserved, remote areas. 

The main services offered include consultation by doctors, supply of medications, testing procedures, surgical procedures, and annual health membership. This integration helps the platform address some of the major gaps in accessing healthcare that exist in rural areas where people have had difficulties accessing strong healthcare facilities.

Operational scale and growth trajectory

The company has present more than 250 clinics throughout India, across seven states. This network is backed by more than 1,800 Swasthya Mitras, 530 trained clinical staff members, 230 doctor partners, and more than 210 partner hospitals and laboratories. 

CureBay has positively impacted over 17 lakh lives and has been actively organizing health camps in the community, with an impact of more than 400 patients every month; clearly, a huge footprint of community engagement and Western healthcare delivery across the varying rural profiles.

CureBay has laid a strong six-layer rural healthcare system where physical clinics are complemented by a dedicated network of community health workers, CureBay’s proprietary digital platform, AI-based screening tools, a 24/7 command center, and CureBay Kavach. 

The startup also works closely with government bodies on healthcare delivery projects beyond just direct-to-consumer operations. CureBay serves as the official healthcare partner for Samriddhi Kendra, a vital healthcare program of the Government of India.

The recent funding round of pre-Series C is a continuation of the successful series of investments received by the organization. Before this round, CureBay had closed a Series B funding round in May 2025 in which it raised $21 million, with Elevar Equity joining British International Investment as an existing investor. The steady capital flow reflects high market trust in CureBay’s business model and its ability to impact health facility access in rural India in the long run.

Conclusion

IvyCap Ventures led a pre-Series C round valued at ₹100 crore on the rural healthcare startup CureBay, marking a significant achievement for the company. The firm can leverage this equity infusion from institutional investors and debt financing from key partners to fund its ambitious expansion in new markets such as Andhra Pradesh and its investments in artificial intelligence and technology initiatives. CureBay has a network of more than 250 clinics across seven states, has treated millions of patients, and has collaborative relationships with the Government of India that will facilitate the transformation of healthcare delivery in underserved rural communities.